About Us
About PEAL Capital
We Partner with Management Teams to Unlock Hidden Value
PEAL Capital is a Europe-based private equity firm focused on the longevity and hormones sector, investing across Western Europe, the UK, and North America. We take controlling or influential minority positions in mature lower-mid-cap businesses and deliver hands-on operational and financial support from acquisition through exit.
Year of
Experience
65+ years combined industry expertise
58 direct investments sourced and managed
2.27× average multiple on cost
Our Mission
To deliver strong, risk-adjusted returns by investing in secondary direct opportunities where our operational expertise and strategic oversight can unlock hidden value and accelerate growth.
Our Values
We believe in disciplined execution, full alignment with management teams, and long-term, sustainable growth. We are committed to integrity, transparency and building lasting partnerships.
Our Guiding Principles
We build trusted partnerships grounded in transparency, discipline and long-term thinking.
We believe successful investing requires more than capital — it takes judgment, patience, and conviction. Our team is guided by a clear set of principles that shape how we invest, govern, and grow each business we support.
Principles That Shape Our Thinking
We hold ourselves to a high standard of discipline, humility and transparency. These values guide how we assess opportunities, support founders, and deliver results — especially in complex or under-managed situations.
Our Approach in Action
From due diligence to value realisation, we bring a rigorous, repeatable approach to decision-making. We act with integrity, remain calm under pressure, and build strong relationships that last beyond the exit.
Reasons to Choose Us
Why Investors Choose PEAL Capital
As the only private equity firm dedicated exclusively to the longevity and hormones sector, PEAL deploys a three-fund strategy that spans the entire supply chain, securing proprietary off-market opportunities and giving investors full-spectrum exposure.
Proprietary deal flow via trusted networks
Deep due diligence based on live portfolio data, not projections
Hands-on value creation through board-level involvement
Targeted exit strategies with reduced holding periods
Strong alignment with management and investors
Track record of consistent, risk-adjusted returns
Senior Team Track Record
Successful Exits
Deal Size Range
Active Governance
Meet Our Team
A Trusted Team With Decades of Investment and Operational Experience
Karen O'Mahony
Founder & Managing Partner
Brendan McDonagh
Chair of PEAL Capital Group
Tara Mandal
Partner & COO